☆ 4.7 Article

Effects of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in P301S Mice Modeling Alzheimer's Disease Tauopathies

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pharmacology & Pharmacy

Low-Intensity Pulsed Ultrasound-Mediated Blood-Brain Barrier Opening Increases Anti-Programmed Death-Ligand 1 Delivery and Efficacy in Gl261 Mouse Model

Mohammed H. H. Ahmed et al.

Summary: Therapeutic antibodies targeting immune checkpoints have limited efficacy in clinical trials for glioblastoma patients. Ultrasound-mediated blood-brain barrier opening (UMBO) improves drug delivery to the brain. In preclinical models of glioblastoma, UMBO combined with immune checkpoint inhibitors showed increased overall survival and improved drug penetration.

PHARMACEUTICS (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics

Jeffrey Cummings

Summary: Two anti-amyloid monoclonal antibodies, lecanemab (Leqembi) and aducanumab (Aduhelm), have been approved in the USA for the treatment of Alzheimer's disease. These breakthrough agents slow the clinical decline of AD by targeting the disease's basic biological processes, supporting the amyloid hypothesis and amyloid as a target for drug development. Monoclonal antibodies bring about a new era in AD therapy and open doors for the development of treatments for various neurodegenerative disorders.

DRUGS (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy

Xiaoying Chen et al.

Summary: Extracellular deposition of amyloid-beta and intracellular accumulation of hyperphosphorylated, aggregated tau are characteristic hallmarks of Alzheimer's disease. The regional progression of brain atrophy highly correlates with tau accumulation, and the mechanisms of tau-mediated neurodegeneration remain elusive. This study reveals a tauopathy- and neurodegeneration-related immune hub involving activated microglia and T cell responses, which could serve as therapeutic targets for preventing neurodegeneration in Alzheimer's disease and primary tauopathies.

NATURE (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial

Catherine J. Mummery et al.

Summary: By inhibiting MAPT expression with a tau-targeting antisense oligonucleotide (MAPTRx), researchers were able to reduce tau levels in patients with mild Alzheimer's disease. A randomized, double-blind trial found that the CSF total-tau protein concentration decreased by more than 50% in patients treated with MAPTRx, with mild adverse effects reported.

NATURE MEDICINE (2023)

添加到收藏夹

Article Acoustics

Safety Profile of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in Non-epileptic Mice and in a Mouse Model of Mesial Temporal Lobe Epilepsy

Bertrand Mathon et al.

Summary: This study aims to investigate whether ultrasound-induced blood-brain barrier (BBB) disruption can promote epileptogenesis and how BBB integrity changes over time after sonication. The results show that low-intensity pulsed ultrasound (LIPU)-induced BBB opening leads to transient albumin extravasation and reversible mild astrogliosis, but does not induce epileptogenicity in non-epileptic mice. These findings provide persuasive evidence for the safety and efficacy of LIPU-induced BBB opening as a therapeutic modality for neurological diseases.

ULTRASOUND IN MEDICINE AND BIOLOGY (2023)

添加到收藏夹

Review Clinical Neurology

Alzheimer's disease drug development pipeline: 2023

Jeffrey Cummings et al.

Summary: There are currently 187 trials assessing 141 drugs for the treatment of Alzheimer's disease (AD). Drugs in the AD pipeline address a variety of pathological processes. More than 57,000 participants will be required to populate all currently registered trials.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2023)

添加到收藏夹

Article Clinical Neurology

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

Stephen Salloway et al.

Summary: The EMERGE and ENGAGE phase 3 trials provided data on ARIA associated with aducanumab treatment in patients with Alzheimer's disease. A high rate of ARIA was observed, with ARIA-edema being the most common adverse event. Some patients in the aducanumab group experienced associated symptoms, with headache being the most common.

JAMA NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device

Stephane Epelbaum et al.

Summary: This study investigated the safety and efficacy of using an implantable ultrasound device to temporarily disrupt the blood-brain barrier (BBB) in patients with mild Alzheimer's disease (AD). The results showed that ultrasound-based BBB disruption was safe and had the potential to be used as a therapy for AD patients.

ALZHEIMERS RESEARCH & THERAPY (2022)

添加到收藏夹

Article Clinical Neurology

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease A Randomized Clinical Trial

Edmond Teng et al.

Summary: In this study, semorinemab did not slow clinical progression in patients with prodromal to mild AD, but demonstrated good safety. Further research is needed to determine the clinical utility of anti-tau antibody therapy.

JAMA NEUROLOGY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy

Rinie Bajracharya et al.

Summary: Tau-specific immunotherapy is a promising treatment strategy for Alzheimer's disease. However, the blood-brain barrier poses a challenge for effective delivery of tau-specific antibodies. Previous research has shown that low-intensity scanning ultrasound combined with microbubbles can increase antibody passage into the brain. This study aimed to assess the therapeutic response of ultrasound-mediated delivery of tau-specific antibodies.

JOURNAL OF CONTROLLED RELEASE (2022)

添加到收藏夹

Review Clinical Neurology

High-clearance anti-amyloid immunotherapies in Alzheimer?s disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects

N. Villain et al.

Summary: In 2021, aducanumab, an immunotherapy targeting amyloid-b, was approved for Alzheimer's disease by the US FDA. This approval has sparked controversy, as the European Medicines Agency refused to allow marketing of the drug and expressed safety concerns. The Centers for Medicare & Medicaid Services also imposed coverage limitations. Other anti-amyloid immunotherapies have shown promise in clinical trials, but their risk/benefit ratio is still questionable after 18 months. The cost of aducanumab in the US may not align with its clinical benefits.

REVUE NEUROLOGIQUE (2022)

添加到收藏夹

Article Neurosciences

Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer's disease: a proof-of-concept study

So Hee Park et al.

Summary: The study aimed to evaluate the safety and potential benefits of repeated extensive BBB opening for patients with AD. Results indicated that the therapy could help remove amyloid plaque to some extent, but further research is needed to ensure the sustainability of the effects.

TRANSLATIONAL NEURODEGENERATION (2021)

添加到收藏夹

Article Clinical Neurology

A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease

Gerhard Leinenga et al.

Summary: The study found that both Adu and SUS reduced the total plaque area in the hippocampus, with no additional effect observed with the combination treatment. In the cortex, only the combination treatment yielded a significant decrease in total plaque area compared to sham. The SUS and SUS + Adu groups were able to significantly reduce plaque load in some animals to below 1% from above 10%. The group receiving the combination treatment showed a robust improvement in spatial memory, and Adu levels were five times higher in this group compared to those receiving Adu alone.

ALZHEIMERS RESEARCH & THERAPY (2021)

添加到收藏夹

Review Geriatrics & Gerontology

The Applications of Focused Ultrasound (FUS) in Alzheimer's Disease Treatment: A Systematic Review on Both Animal and Human Studies

Xiaodan Liu et al.

Summary: FUS with microbubbles can open the blood-brain barrier in animal studies, allowing therapeutic agents to enter the brain. The treatment is well tolerated in human studies and has shown cognitive improvement, but further optimization is needed.

AGING AND DISEASE (2021)

添加到收藏夹

Article Oncology

Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations

Daniel Y. Zhang et al.

CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Immunology

The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease

Yao Sun et al.

JOURNAL OF NEUROINFLAMMATION (2020)

添加到收藏夹

Review Geriatrics & Gerontology

Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain

William M. Pardridge

FRONTIERS IN AGING NEUROSCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Improvement of glymphatic-lymphatic drainage of beta-amyloid by focused ultrasound in Alzheimer's disease model

Youngsun Lee et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease

Sonam Dubey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Oncology

Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Ahmed Idbaih et al.

CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Repeated ultrasound treatment of tau transgenic mice clears neuronal tau by autophagy and improves behavioral functions

Rucha Pandit et al.

THERANOSTICS (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Unilateral Focused Ultrasound-Induced Blood-Brain Barrier Opening Reduces Phosphorylated Tau from The rTg4510 Mouse Model

Maria Eleni Karakatsani et al.

THERANOSTICS (2019)

添加到收藏夹

Review Medicine, Research & Experimental

Principles and approaches for reproducible scoring of tissue stains in research

David K. Meyerholz et al.

LABORATORY INVESTIGATION (2018)

添加到收藏夹

Article Neurosciences

Safety and Efficacy of Scanning Ultrasound Treatment of Aged APP23 Mice

Gerhard Leinenga et al.

FRONTIERS IN NEUROSCIENCE (2018)

添加到收藏夹

Article Neurosciences

Absence of CX3CR1 impairs the internalization of Tau by microglia

Marta Bolos et al.

MOLECULAR NEURODEGENERATION (2017)

添加到收藏夹

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Clinical Neurology

Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model

Rebecca M. Nisbet et al.

BRAIN (2017)

添加到收藏夹

Article Cell Biology

Clinical trial of blood-brain barrier disruption by pulsed ultrasound

Alexandre Carpentier et al.

SCIENCE TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Article Clinical Neurology

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain

Nicole Maphis et al.

BRAIN (2015)

添加到收藏夹

Article Neurosciences

Depletion of microglia and inhibition of exosome synthesis halt tau propagation

Hirohide Asai et al.

NATURE NEUROSCIENCE (2015)

添加到收藏夹

Article Cell Biology

Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model

Gerhard Leinenga et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Proteopathic tau seeding predicts tauopathy in vivo

Brandon B. Holmes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Alzheimer Disease in a Mouse Model: MR Imaging-guided Focused Ultrasound Targeted to the Hippocampus Opens the Blood-Brain Barrier and Improves Pathologic Abnormalities and Behavior

Alison Burgess et al.

RADIOLOGY (2014)

添加到收藏夹

Article Neurosciences

Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound

Jessica F. Jordao et al.

EXPERIMENTAL NEUROLOGY (2013)

添加到收藏夹

Article Neurosciences

Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β

Bernd Bohrmann et al.

JOURNAL OF ALZHEIMERS DISEASE (2012)

添加到收藏夹

Review Clinical Neurology

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Peter T. Nelson et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

添加到收藏夹

Article Multidisciplinary Sciences

Antibodies Targeted to the Brain with Image-Guided Focused Ultrasound Reduces Amyloid-β Plaque Load in the TgCRND8 Mouse Model of Alzheimer's Disease

Jessica F. Jordao et al.

PLOS ONE (2010)

添加到收藏夹

Article Acoustics

MULTI-MODALITY SAFETY ASSESSMENT OF BLOOD-BRAIN BARRIER OPENING USING FOCUSED ULTRASOUND AND DEFINITY MICROBUBBLES: A SHORT-TERM STUDY

Babak Baseri et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2010)

添加到收藏夹

Article Cell Biology

Transmission and spreading of tauopathy in transgenic mouse brain

Florence Clavaguera et al.

NATURE CELL BIOLOGY (2009)

添加到收藏夹

Article Acoustics

Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium

Nickolai Sheikov et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2008)

添加到收藏夹

Article Neurosciences

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

Yasumasa Yoshiyama et al.

NEURON (2007)

添加到收藏夹

Article Biochemistry & Molecular Biology

Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice

D Terwel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

添加到收藏夹

Article Acoustics

Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles

N Sheikov et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2004)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits

K Hynynen et al.

RADIOLOGY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.